U.S. Markets closed

Illumina Inc (ILMN) Files 10-K for the Fiscal Year Ended on December 31, 2018

- By insider

Illumina Inc (ILMN) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products. Illumina Inc has a market cap of $42.44 billion; its shares were traded at around $288.73 with a P/E ratio of 51.93 and P/S ratio of 12.87. Illumina Inc had annual average EBITDA growth of 23.00% over the past ten years. GuruFocus rated Illumina Inc the business predictability rank of 5-star.


For the last quarter Illumina Inc reported a revenue of $867.0 million, compared with the revenue of $777.0 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $3.3 billion, an increase of 21.1% from last year. For the last five years Illumina Inc had an average revenue growth rate of 17.1% a year.

The reported diluted earnings per share was $5.56 for the year, an increase of 13% from previous year. Over the last five years Illumina Inc had an EPS growth rate of 38.1% a year. The Illumina Inc enjoyed an operating margin of 26.49%, compared with the operating margin of 22.02% a year before. The 10-year historical median operating margin of Illumina Inc is 23.11%. The profitability rank of the company is 9 (out of 10).

At the end of the fiscal year, Illumina Inc has the cash and cash equivalents of $1.1 billion, compared with $1.2 billion in the previous year. The long term debt was $890.0 million, compared with $1.2 billion in the previous year. Illumina Inc has a financial strength rank of 7 (out of 10).

At the current stock price of $288.73, Illumina Inc is traded at 28% premium to its historical median P/S valuation band of $225.59. The P/S ratio of the stock is 12.87, while the historical median P/S ratio is 10.06. The intrinsic value of the stock is $158.28 a share, according to GuruFocus DCF Calculator. The stock gained 30.93% during the past 12 months.

CEO Recent Trades:

  • President and CEO Francis A Desouza sold 3,000 shares of ILMN stock on 02/01/2019 at the average price of $282.95. The price of the stock has increased by 2.04% since.

Directors and Officers Recent Trades:

  • Director Robert S Epstein sold 1,000 shares of ILMN stock on 02/01/2019 at the average price of $280.11. The price of the stock has increased by 3.08% since.
  • SVP & General Counsel Charles Dadswell sold 124 shares of ILMN stock on 02/01/2019 at the average price of $280.11. The price of the stock has increased by 3.08% since.
  • Director Jay T Flatley sold 3,300 shares of ILMN stock on 01/23/2019 at the average price of $303.53. The price of the stock has decreased by 4.88% since.

For the complete 20-year historical financial data of ILMN, click here.

This article first appeared on GuruFocus.